Results 161 to 170 of about 234,206 (306)

Reviewer #2 (Public review): Therapeutic effects of PDGF-AB/BB against cellular senescence in human intervertebral disc

open access: gold
Changli Zhang   +6 more
openalex   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

open access: yesMolecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj   +4 more
wiley   +1 more source

PRKN-Mediated Ubiquitin-Proteasome Degradation of METTL3 Promotes Cellular Senescence. [PDF]

open access: yesAging Cell
Chen L   +14 more
europepmc   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Cellular Senescence

open access: yesReactome - a curated knowledgebase of biological pathways, 2013
openaire   +1 more source

Author Correction: RNaseH2A downregulation drives inflammatory gene expression via genomic DNA fragmentation in senescent and cancer cells

open access: yesCommunications Biology
Sho Sugawara   +20 more
doaj   +1 more source

The impact of cellular senescence on aging skeletal muscle. [PDF]

open access: yesFront Cell Dev Biol
Kamal M   +3 more
europepmc   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Cellular senescence in age-related cardiovascular disease: past and future. [PDF]

open access: yesFront Aging
Wu X   +14 more
europepmc   +1 more source

Mir‐23a induces telomere dysfunction and cellular senescence by inhibiting TRF2 expression [PDF]

open access: gold, 2015
Zhenhua Luo   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy